ANIP
ANI Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
4.28 / 10
Netural
ANI Pharmaceuticals shows moderate fundamental strength with a score of 4.3 out of 10. Key positives include an interest coverage ratio of 5.11, indicating solid interest payment capacity, and strong revenue growth of 50.14% year-over-year. However, concerns arise from a high days sales outstanding of 100.64, reflecting slow receivable collection, and a PB-ROE of 0.36 that lags peers. These factors collectively suggest a challenging investment verdict despite some solid operational metrics.
Analysis Checks(8/10)
Revenue-MV
Value-0.10
Score2/3
Weight14.78%
1M Return7.73%
Value-0.10
Score2/3
Weight14.78%
1M Return7.73%
Days sales outstanding
Value100.64
Score0/3
Weight-6.67%
1M Return-5.18%
Value100.64
Score0/3
Weight-6.67%
1M Return-5.18%
Net income-Revenue
Value-0.20
Score2/3
Weight15.07%
1M Return8.45%
Value-0.20
Score2/3
Weight15.07%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value5.11
Score2/3
Weight-1.51%
1M Return-1.11%
Value5.11
Score2/3
Weight-1.51%
1M Return-1.11%
Asset-MV
Value-0.50
Score3/3
Weight27.91%
1M Return13.15%
Value-0.50
Score3/3
Weight27.91%
1M Return13.15%
Total operating revenue (YoY growth rate %)
Value50.14
Score2/3
Weight1.61%
1M Return1.11%
Value50.14
Score2/3
Weight1.61%
1M Return1.11%
Profit-MV
Value0.16
Score2/3
Weight15.05%
1M Return8.45%
Value0.16
Score2/3
Weight15.05%
1M Return8.45%
PB-ROE
Value0.36
Score1/3
Weight18.33%
1M Return9.57%
Value0.36
Score1/3
Weight18.33%
1M Return9.57%
Operating revenue (YoY growth rate %)
Value50.14
Score2/3
Weight0.62%
1M Return0.43%
Value50.14
Score2/3
Weight0.62%
1M Return0.43%
Cash-MV
Value-0.28
Score2/3
Weight14.80%
1M Return8.41%
Value-0.28
Score2/3
Weight14.80%
1M Return8.41%
Revenue-MV
Value-0.10
Score2/3
Weight14.78%
1M Return7.73%
Value-0.10
Score2/3
Weight14.78%
1M Return7.73%
Total operating revenue (YoY growth rate %)
Value50.14
Score2/3
Weight1.61%
1M Return1.11%
Value50.14
Score2/3
Weight1.61%
1M Return1.11%
Days sales outstanding
Value100.64
Score0/3
Weight-6.67%
1M Return-5.18%
Value100.64
Score0/3
Weight-6.67%
1M Return-5.18%
Profit-MV
Value0.16
Score2/3
Weight15.05%
1M Return8.45%
Value0.16
Score2/3
Weight15.05%
1M Return8.45%
Net income-Revenue
Value-0.20
Score2/3
Weight15.07%
1M Return8.45%
Value-0.20
Score2/3
Weight15.07%
1M Return8.45%
PB-ROE
Value0.36
Score1/3
Weight18.33%
1M Return9.57%
Value0.36
Score1/3
Weight18.33%
1M Return9.57%
Interest coverage ratio (EBIT / Interest expense) (%)
Value5.11
Score2/3
Weight-1.51%
1M Return-1.11%
Value5.11
Score2/3
Weight-1.51%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value50.14
Score2/3
Weight0.62%
1M Return0.43%
Value50.14
Score2/3
Weight0.62%
1M Return0.43%
Asset-MV
Value-0.50
Score3/3
Weight27.91%
1M Return13.15%
Value-0.50
Score3/3
Weight27.91%
1M Return13.15%
Cash-MV
Value-0.28
Score2/3
Weight14.80%
1M Return8.41%
Value-0.28
Score2/3
Weight14.80%
1M Return8.41%
Is ANIP undervalued or overvalued?
- ANIP scores 4.28/10 on fundamentals and holds a Fair valuation at present. Backed by its 10.64% ROE, 4.91% net margin, -155.27 P/E ratio, 3.63 P/B ratio, and 463.83% earnings growth, these metrics solidify its Netural investment rating.
